Clearstead Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Hold
83,423
0.01% 480
2026
Q1
$1.18M Sell
83,423
-1,000
-1% -$14.7K 0.01% 469
2025
Q4
$1.2M Hold
84,423
0.02% 426
2025
Q3
$1.25M Hold
84,423
0.02% 402
2025
Q2
$1.28M Buy
84,423
+1,003
+1% +$14.6K 0.02% 391
2025
Q1
$1.2M Buy
83,420
+960
+1% +$14.7K 0.02% 377
2024
Q4
$1.25M Buy
82,460
+1,499
+2% +$24.1K 0.02% 368
2024
Q3
$1.33M Sell
80,961
-6,688
-8% -$110K 0.02% 363
2024
Q2
$1.44M Buy
+87,649
New +$1.41M 0.02% 326

Other funds holding BCAT

Clearstead Advisors's BCAT Position: Q2 2026 in Review

Clearstead Advisors held its BlackRock Capital Allocation Term Trust (BCAT) position steady in Q2 2026 at 83,423 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #480.

Clearstead Advisors first reported a position in BCAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.44M in Q2 2024. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • Clearstead Advisors held 83,423 shares of BlackRock Capital Allocation Term Trust worth $1.33M as of Q2 2026.
  • Clearstead Advisors left its BlackRock Capital Allocation Term Trust share count unchanged in Q2 2026.
  • BlackRock Capital Allocation Term Trust made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #480 holding.
  • Clearstead Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and has held it in 9 quarters since.
  • Clearstead Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.44M in Q2 2024.
  • 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.